Results 11 to 20 of about 1,230,040 (315)

Liver Transplant for Cholestatic Liver Diseases

Clinics in Liver Disease, 2013
Cholestatic liver diseases include a group of diverse disorders with different epidemiology, pathophysiology, clinical course, and prognosis. Despite significant advances in the clinical care of patients with cholestatic liver diseases, liver transplant (LT) remains the only definitive therapy for end-stage liver disease, regardless of the underlying ...
Andres F, Carrion, Kalyan Ram, Bhamidimarri   +1 more
openaire   +3 more sources

Role of bile acids in inflammatory liver diseases [PDF]

, 2021
Bile acids and their signaling pathways are increasingly recognized as potential therapeutic targets for cholestatic and metabolic liver diseases. This review summarizes new insights in bile acid physiology, focusing on regulatory roles of bile acids in ...
Kuipers, Folkert, Verkade, Esther, Kuipers, Folkert; id_orcid, Heeren, Joerg, Evangelakos, Ioannis   +4 more
core   +1 more source

Vascular liver diseases: A sex-oriented analysis of the literature

, 2022
Vascular liver diseases are an heterogenous group of diseases that collectively represent an important health issue in the field of liver diseases. This narrative review was elaborated by the Special Interest Group (SIG) “Gender in Hepatology” of the ...
Merli M., Shalaby S., Zanetto A., Burra P., Morelli M. C., Morisco F., Toniutto P., Becchetti C., Cossiga V., Guarino M., Invernizzi F., Lapenna L.   +11 more
core   +2 more sources

Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. [PDF]

, 2011
This review summarizes the document elaborated by the Italian Association for the Study of the Liver (AISF) ad hoc committee "Vascular disorders of the liver" on the primary circulatory liver diseases, which include Budd-Chiari syndrome, obstruction of ...
Riggio O, Sacerdoti D, Senzolo M, Primignani M, Italian Association for the Study of the Liver AISF ad hoc committee Vascular disorders of the liver, SACERDOTI, DAVID   +5 more
core   +1 more source

Liver diseases and aging:friends or foes? [PDF]

, 2013
The liver is the only internal human organ capable of natural regeneration of lost tissue, as little as 25% of a liver can regenerate into a whole liver. The process of aging predisposes to hepatic functional and structural impairment and metabolic risk.
Koonen, Debby; id_orcid, Stefano Di Biase, Koonen, Debby, Vinciguerra, M, Vinciguerra, Manlio, Sheedfar, Fareeba, Di Biase, Stefano, Debby Koonen, Sheedfar, F, Fareeba Sheedfar, Manlio Vinciguerra, Koonen, D, Di Biase, S   +12 more
core   +1 more source

Iron and Liver Diseases [PDF]

Canadian Journal of Gastroenterology and Hepatology, 1999
A mild to moderate iron excess is found in patients with liver diseases apparently unrelated to genetic hemochromatosis. Iron appears to affect the natural history of hepatitis C virus‐related chronic liver diseases, alcoholic liver disease and nonalcoholic steatohepatitis by leading to a more severe fibrosis and thus aiding the evolution to cirrhosis ...
S.R. Fargion, M. Mattioli, A.L. Fracanzani, G. Fiorelli   +3 more
openaire   +5 more sources

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection [PDF]

, 2008
Autoimmune liver diseases, such as autoimmune hepatitis (AIH) and primary biliary cirrhosis, often have severe consequences for the patient. Because of a lack of appropriate animal models, not much is known about their potential viral etiology. Infection
Hintereder, Gudrun, Gudrun Hintereder, Michael P. Manns, Christen, Urs, Herrath, Matthias G. von, Holdener, Martin, Monika Bayer, Johnson, Eric F., Urs Christen, Rodrigo, Evelyn, Frank J. Gonzalez, Pfeilschifter, Josef (Prof. Dr.), Eric F. Johnson, Evelyn Rodrigo, Gonzalez, Frank J., Martin Holdener, Edith Hintermann, Hintermann, Edith, Matthias von G. Herrath, Josef Pfeilschifter, Rhode, Antje, Bayer, Monika, Manns, Michael P., Antje Rhode   +23 more
core   +1 more source

New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study

Artificial Cells, Nanomedicine, and Biotechnology, 2023
We intended to identify favourable metabolite(s) and pharmacological mechanism(s) of gut microbiota (GM) for liver regeneration (LR) through network pharmacology.
Ki-Kwang Oh, Ickwon Choi, Haripriya Gupta, Ganesan Raja, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk   +18 more
doaj   +1 more source

Dual graft living donor liver transplantation – a case report

BMC Surgery, 2019
Background Living donor liver transplantation (LDLT) has emerged as an equally viable option to deceased donor liver transplant for treating end stage liver disease patients.
Nikam Vinayak, Mohanka Ravi, Golhar Ankush, Bhade Rashmi, Rao Prashantha, Gadre Parul, Shrimal Anurag   +6 more
doaj   +1 more source

Chemerin in Liver Diseases [PDF]

, 2014
Chemerin is a chemoattractant protein and moreover has a role in adipogenesis, angiogenesis and glucose homeostasis. Chemerin is primarily synthesized and secreted by adipocytes and hepatocytes.
Buechler, Christa
core   +1 more source